Barbara-Jean Anne Bormann-Kennedy

Director · 1 filing · Latest: Jun 4, 2026

Xeris Biopharma Holdings, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
XERS	Barbara-Jean Anne Bormann-Kennedy	Director	Jun 4, 2026	Grant/Award	$0.00	24,193	—	150,693	Jun 5 6:18 PM
XERS	Barbara-Jean Anne Bormann-Kennedy	Director	Jun 4, 2026	Sale	$6.09	16,000	$97.5K	126,500	Jun 5 6:18 PM